We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: CP27830
CAS No: 959583-56-3
Synonyms/Alias: 959583-56-3 ;FMOC-BETA-(BENZOTHIAZOL-2-YL)-L-ALANINE ;(2S)-3-(1,3-benzothiazol-2-yl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid ;(alphaS)-alpha-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-benzothiazolepropanoic acid ;MFCD03791021 ;(2S)-3-(1,3-benzothiazol-2-yl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid ;AKOS030212435 ;E70675 ;N-alpha-(9-Fluorenylmethyloxycarbonyl)-benZothiaZol-2-yl-L-alanine (Fmoc-L-Ala(Bth)-OH) ;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C25H20N2O4S |
M.W/Mr. | 444.5 |
Sequence | Three Letter Code:Fmoc-Ala(benzothiazol-2-yl)(benzothiazol-2-yl)-OH |
InChI | InChI=1S/C25H20N2O4S/c28-24(29)21(13-23-26-20-11-5-6-12-22(20)32-23)27-25(30)31-14-19-17-9-3-1-7-15(17)16-8-2-4-10-18(16)19/h1-12,19,21H,13-14H2,(H,27,30)(H,28,29)/t21-/m0/s1 |
InChI Key | FOEQAVDISWFCSU-NRFANRHFSA-N |
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com